With the advent of new technological advancements in medical research and diagnostic strategies, early disease diagnosis and prevention has witnessed a medical revolution. We are proud to present to you our ‘OncoGene’ ConfEx in London scheduled on 9th – 10th March 2023. This ConfEx is an assemblage of 3 inextricably linked conferences like 7th Annual Next-Gen Immuno-Oncology Conference, Next-Gen Genomics and Proteomics Conference and Precision Medicine Conference which will accommodate diverse sessions on cutting edge discussions via Presentations, Exhibitions, Speaker QnAs, Panel discussions or Breakout sessions.
The ConfEx aims to bring together the full spectrum of experts, leaders and shareholders from global pharmaceutical organizations, biotech and therapeutical companies, and internationally eminent research and academic institutions to share broad perspective on advancements and solutions to most critical challenges in the areas of Immuno-Oncology, Advancements in Genomics and Proteomics and Personalized Medicine Approaches.
The eagerly anticipated ConfEx is intended to have interactive sessions on the application of each area in complex disease prediction, quantitative analysis of genomic and proteomic tools and federal efforts in developing the hyperindividualized therapy. The discussion also encompasses the latest advantages of clinical data,digitalization in healthcare and dynamic therapeutic innovations.
